Karolinska Development and Kurma Biofund to enter strategic partnership
(Thomson Reuters ONE) -
STOCKHOLM, June 29, 2010. Karolinska Development AB and Kurma Biofund have
entered into a strategic partnership, with the purpose to identify co-investment
opportunities in the life science area in the Nordic region and other selected
parts of Europe.
The Karolinska Development and Kurma Biofund combination will increase the
possibilities for early life science investments in world class science. The
strategic Karolinska Development and Kurma Biofund partnership will further
contribute to cross European investments.
Conny Bogentoft, CEO Karolinska Development;
"We are excited to broaden our co-investor network for early stage financing.
With Kurma we also add a broader dealflow outside of Scandinavia and add a
competent partner to our network."
Thierry Laugel, joint Managing Partner Kurma Biofund;
"With Karolinska Development, Kurma is proud to add such an eminent group to the
very selective network of partners around Europe. We are currently looking at a
number of co- investment opportunities that would clearly exemplify the
complementarities and synergies between our two groups."
For further information, please contact:
Karolinska Development
Conny Bogentoft: +46 (0) 706 88 61 43
conny.bogentoft(at)karolinskadevelopment.com
Kurma Biofund
Thierry Laugel : +33 (0) 1 58 50 91 09
Thierruy.laugel(at)kurmabiofund.com
About Karolinska Development
Karolinska Development manages one of the largest portfolios of life science
companies in Europe. Using a unique business model, the company cost efficiently
guides the commercialization of world class life science innovations. Since its
inception in 2003, Karolinska Development has built a portfolio of some 40
companies. Among the company's projects, 12 candidate drugs are undergoing
clinical trials and it is estimated that a total of 21 substances have
first-in-class potential.www.karolinskadevelopment.com
About Kurma Biofund
Kurma Biofund is a new venture capital fund based in Paris and dedicated to
innovations in Life Sciences and Healthcare. The fund has a unique positioning
based on financing assets with near term realizations (3 to 5 years) for both
technology transfer projects and mature projects. Kurma relies on very high
quality investment opportunities generated through a network of partnerships in
France and abroad with leading research institutes and a strong experienced team
combining managing partners, venture partners and a strong network of scientific
experts. Kurma Biofund I has closed a first round of financing of 50 million
euros on the 24th November 2009.www.kurmabiofund.com
[HUG#1428068]
Read Press Release as PDF: http://hugin.info/143071/R/1428068/375605.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Karolinska Development AB (publ) via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 29.06.2010 - 17:11 Uhr
Sprache: Deutsch
News-ID 23197
Anzahl Zeichen: 0
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 264 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Karolinska Development and Kurma Biofund to enter strategic partnership"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
